This session from our 2025 International Symposium on Malignant Mesothelioma was filmed on October 26th in Philadelphia, Pennsylvania. Kevin Blyth, MD, from University of Glasgow presents on Imaging in the Future with AI. This presentation explores how artificial intelligence (AI) is transforming medical imaging for mesothelioma diagnosis, treatment planning, and monitoring. Attendees will learn how AI technologies are enhancing the accuracy of imaging interpretation, enabling earlier detection, and supporting more personalized treatment decisions. The session will highlight current research, practical applications in radiology, and what patients and families can expect from these innovations in the near future. By understanding how AI integrates with traditional imaging methods, participants will gain insight into how these advances may improve outcomes and streamline care for mesothelioma patients.
This is a recording of a session at the 2025 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Dean Omar Branham Shirley, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); The Gori Law Firm; MERCK; AstraZeneca; Early Lucarelli Sweeney & Meisenkothen
Find other recorded sessions and more information at www.curemeso.org/symposium
